ABAnna Both

Anna Both

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna Both has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Rapid development of cefiderocol resistance in a carbapenem-resistant Pseudomonas aeruginosa isolate associated with mutations in the pyoverdine biosynthesis pathway

    by Luise Brakert, Laura Berneking, Anna Both, Benjamin Berinson, Jiabin Huang, Martin Aepfelbacher, Christine Wolschke, Dominic Wichmann, Holger Rohde


  • Open Access

    Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis

    by Laura Berneking, Anna Both, Claudia Langebrake, Martin Aepfelbacher, Marc Lütgehetmann, Nicolaus Kröger, Maximilian Christopeit

    Introduction: Human herpesvirus 6 (HHV‐6) can reactivate after allogeneic hematopoietic stem cell transplantation (allo‐HSCT) and may be associated with significant morbidity and mortality.Methods: The epidemiology of HHV‐6 infections and their impact on outcome after allo‐HSCT were retrospectively analyzed in 689 adult allo‐HSCT recipients (January 2015–December 2018). Chromosomal integration of HHV‐6 (ciHHV‐6) in the donor was retrospectively investigated to critically evaluate antiviral treatment strategies.Results: HHV‐6 DNA in any specimen was found in 89 patients. HHV‐6 infections (encephalitis (one), gastroenteritis (44), dermatitis (two), hepatitis (one), or pneumonitis (five)) were diagnosed in 53/689 patients (7.7%). Elevated levels of HHV‐6 DNA were found in 38 patients (5.5%). ciHHV‐6, analyzed in patients with HHV‐6 viral loads ≥104 copies/ml, was identified in four patients (10/38 patients; 10.5%). Two of those displayed copy numbers of HHV‐6 ranging from ≥2 × 105 to 2.5 × 106 copies/ml (HHV‐6A). Here, ciHHV‐6 was integrated into donor and not into the patients’ cells. In this series of allo‐HSCT recipients, 10.5% of patients with blood viral loads of HHV‐6 showed ciHHV‐6.Conclusion: Screening of the donor for ciHHV‐6 before initiation of antiviral therapy is recommended. image


  • Open Access

    Evaluation of a syndromic panel polymerase chain reaction (spPCR) assay for the diagnosis of device‐associated bone and joint infections (BJI)

    by Laura Berneking, Michaela Haas, Lisa Frielinghaus, Benjamin Berinson, Marc Lütgehetmann, Martin Christner, Martin Aepfelbacher, Ulf Gerlach, Klaus Seide, Anna Both, et al.


  • Open Access

    Performance of a loop-mediated isothermal amplification assay (Isoplex CRE-ART) to detect common carbapenemase-encoding genes in Gram-negative bacteria

    by Laura Berneking, Lucia Asar, Anna Both, Benjamin Berinson, Martin Aepfelbacher, Marc Lütgehetmann, Holger Rohde

    Carbapenem-resistant Gram-negative bacteria (CR-GNB) are a major source of nosocomial infections worldwide. In this study, the ability of a loop-mediated isothermal amplification (LAMP)-based method (Isoplex CRE-ART) to rapidly detect carbapenemase-encoding genes bla OXA-48-like, bla OXA-23-like, bla OXA-24-like, bla KPC, bla VIM, bla NDM and bla IMP in 231 carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii isolates was investigated. The accuracy of the LAMP test was compared to results of molecular isolate characterization using a Laboratory Developed Test multiplex carbapenemase PCR assay. The LAMP test correctly identified the presence of on-panel carbapenemases with a sensitivity of 99.16 % [95 % confidence interval (CI): 95.39–99.96 %] and a specificity of 98.21 % (95 % CI: 93.72–99.68 %) in 60 min. Our findings suggest that the Isoplex CRE-ART assay is able to rapidly identify carbapenemase genes in CR-GNB and improves options for pathogen characterization in the context of clinical microbiological and infection control diagnostics.


  • Staphylococcus epidermidis clones express Staphylococcus aureus-type wall teichoic acid to shift from a commensal to pathogen lifestyle

    by Xin Du, Jesper Larsen, Min Li, Axel Walter, Christoph Slavetinsky, Anna Both, Patricia M. Sanchez Carballo, Marc Stegger, Esther Lehmann, Yao Liu, et al.

    Most clonal lineages of Staphylococcus epidermidis are commensals present on human skin and in the nose. However, some globally spreading healthcare-associated and methicillin-resistant S. epidermidis (HA-MRSE) clones are major causes of difficult-to-treat implant or bloodstream infections. The molecular determinants that alter the lifestyle of S. epidermidis have remained elusive, and their identification might provide therapeutic targets. We reasoned that changes in surface-exposed wall teichoic acid (WTA) polymers of S. epidermidis, which potentially shape host interactions, may be linked to differences between colonization and infection abilities of different clones. We used a combined epidemiological and functional approach to show that while commensal clones express poly-glycerolphosphate WTA, S. epidermidis multilocus sequence type 23, which emerged in the past 15 years and is one of the main infection-causing HA-MRSE clones, contains an accessory genetic element, tarIJLM, that leads to the production of a second, Staphylococcus aureus-type WTA (poly-ribitolphosphate (RboP)). Production of RboP-WTA by S. epidermidis impaired in vivo colonization but augmented endothelial attachment and host mortality in a mouse sepsis model. tarIJLM was absent from commensal human sequence types but was found in several other HA-MRSE clones. Moreover, RboP-WTA enabled S. epidermidis to exchange DNA with S. aureus via siphovirus bacteriophages, thereby creating a possible route for the inter-species exchange of methicillin resistance, virulence and colonization factors. We conclude that tarIJLM alters the lifestyle of S. epidermidis from commensal to pathogenic and propose that RboP-WTA might be a robust target for preventive and therapeutic interventions against MRSE infections.


  • Open Access

    Implementation of a multidisciplinary infections conference improves the treatment of spondylodiscitis

    by D. Ntalos, B. Schoof, D. M. Thiesen, L. Viezens, H. Kleinertz, H. Rohde, A. Both, A. Luebke, A. Strahl, M. Dreimann, et al.

    Establishing a multidisciplinary approach regarding the treatment of spondylodiscitis and analyzing its effect compared to a single discipline approach. 361 patients diagnosed with spondylodiscitis were included in this retrospective pre-post intervention study. The treatment strategy was either established by a single discipline approach (n = 149, year 2003–2011) or by a weekly multidisciplinary infections conference (n = 212, year 2013–2018) consisting of at least an orthopedic surgeon, medical microbiologist, infectious disease specialist and pathologist. Recorded data included the surgical and antibiotic strategy, complications leading to operative revision, recovered microorganisms, as well as the total length of hospital and intensive care unit stay. Compared to a single discipline approach, performing the multidisciplinary infections conference led to significant changes in anti-infective and surgical treatment strategies. Patients discussed in the conference showed significantly reduced days of total antibiotic treatment (66 ± 31 vs 104 ± 31, p < 0.001). Moreover, one stage procedures and open transpedicular screw placement were more frequently performed following multidisciplinary discussions, while there were less involved spinal segments in terms of internal fixation as well as an increased use of intervertebral cages instead of autologous bone graft (p < 0.001). Staphylococcus aureus and Staphylococcus epidermidis were the most frequently recovered organisms in both patient groups. No significant difference was found comparing inpatient complications between the two groups or the total in-hospital stay. Implementation of a weekly infections conference is an effective approach to introduce multidisciplinarity into spondylodiscitis management. These conferences significantly altered the treatment plan compared to a single discipline approach. Therefore, we highly recommend the implementation to optimize treatment modalities for patients.


  • Open Access

    Distinct clonal lineages and within-host diversification shape invasive Staphylococcus epidermidis populations

    by Anna Both, Jiabin Huang, Minyue Qi, Christian Lausmann, Samira Weißelberg, Henning Büttner, Susanne Lezius, Antonio Virgilio Failla, Martin Christner, Marc Stegger, et al.

    S.epidermidisis a substantial component of the human skin microbiota, but also one of the major causes of nosocomial infection in the context of implanted medical devices. We here aimed to advance the understanding ofS.epidermidisgenotypes and phenotypes conducive to infection establishment. Furthermore, we investigate the adaptation of individual clonal lines to the infection lifestyle based on the detailed analysis of individualS.epidermidispopulations of 23 patients suffering from prosthetic joint infection. Analysis of invasive and colonizingS.epidermidisprovided evidence that invasiveS.epidermidisare characterized by infection-supporting phenotypes (e.g. increased biofilm formation, growth in nutrient poor media and antibiotic resistance), as well as specific genetic traits. The discriminating gene loci were almost exclusively assigned to the mobilome. Here, in addition to IS256and SCCmec, chromosomally integrated phages was identified for the first time. These phenotypic and genotypic features were more likely present in isolates belonging to sequence type (ST) 2. By comparing seven patient-matched nasal and invasiveS.epidermidisisolates belonging to identical genetic lineages, infection-associated phenotypic and genotypic changes were documented. Besides increased biofilm production, the invasive isolates were characterized by better growth in nutrient-poor media and reduced hemolysis. By examining several colonies grown in parallel from each infection, evidence for genetic within-host population heterogeneity was obtained. Importantly, subpopulations carrying IS insertions inagrC, mutations in the acetate kinase (AckA) and deletions in the SCCmecelement emerged in several infections. In summary, these results shed light on the multifactorial processes of infection adaptation and demonstrate howS.epidermidisis able to flexibly repurpose and edit factors important for colonization to facilitate survival in hostile infection environments.


  • First report of Escherichia coli co-producing NDM-1 and OXA-232

    by Anna Both, Jiabin Huang, Martin Kaase, Julia Hezel, Daniel Wertheimer, Ines Fenner, Thomas Günther, Adam Grundhoff, Henning Büttner, Martin Aepfelbacher, et al.